{
    "clinical_study": {
        "@rank": "60535", 
        "arm_group": [
            {
                "arm_group_label": "SMT19969", 
                "arm_group_type": "Experimental", 
                "description": "200 mg capsule of SMT19969 twice a day for 10 days with alternating 200 mg placebo twice a day"
            }, 
            {
                "arm_group_label": "Vancomycin", 
                "arm_group_type": "Active Comparator", 
                "description": "125 mg capsule four times a day for 10 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study is to evaluate the safety and effectiveness of a new oral\n      antibiotic called SMT19969 in treating C. difficile Infection (CDI)."
        }, 
        "brief_title": "A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)", 
        "condition": "Clostridium Difficile Infection", 
        "condition_browse": {
            "mesh_term": "Clostridium Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent\n\n          -  Clinical diagnosis of CDAD plus laboratory diagnostic test\n\n          -  No more than 24 hrs antimicrobial treatment for current CDAD episode\n\n          -  No more than 2 episodes of CDAD in prior 12 months\n\n          -  No previous episode of CDAD within 60 days of study enrollment\n\n          -  Female subjects of childbearing potential must use adequate contraception\n\n        Exclusion Criteria:\n\n          -  Life-threatening or fulminant colitis\n\n          -  Concurrent use of antibiotics or any other treatments for CDAD\n\n          -  History of inflammatory bowel disease (ulcerative colitis, Crohn's disease)\n\n          -  Participation in other Clinical research studies within one month of screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02092935", 
            "org_study_id": "SMT19969/C002"
        }, 
        "intervention": [
            {
                "arm_group_label": "SMT19969", 
                "intervention_name": "SMT19969", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Vancomycin", 
                "intervention_name": "Vancomycin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Vancomycin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "CDAD", 
            "Clostridium Difficile"
        ], 
        "lastchanged_date": "April 18, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sylmar", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Idaho Falls", 
                        "country": "United States", 
                        "state": "Idaho"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Novi", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tupelo", 
                        "country": "United States", 
                        "state": "Mississippi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Butte", 
                        "country": "United States", 
                        "state": "Montana"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sommers Point", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)", 
        "other_outcome": {
            "description": "Using microbiology, sequencing, metagenomic and bioinformatics techniques.", 
            "measure": "To assess the qualitative and quantitative effect of SMT19969 and Vancomycin on the bowel flora of subjects", 
            "safety_issue": "No", 
            "time_frame": "40 days"
        }, 
        "overall_contact": {
            "email": "Codify@summitplc.com", 
            "last_name": "Ian Foley, Ph.D", 
            "phone": "+44 1235-443-937"
        }, 
        "overall_official": {
            "affiliation": "Summit Corporation Plc.", 
            "last_name": "David Roblin, MD, FRCP", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Sustained clinical response is defined as clinical cure at the Test of Cure Visit (Day 12) and no recurrence of CDAD within 30 days of End of Therapy", 
            "measure": "Evaluate the clinical outcome by assessment of sustained clinical response", 
            "safety_issue": "No", 
            "time_frame": "30 days post End of Therapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02092935"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Using laboratory analysis", 
                "measure": "Plasma and faecal concentrations of SMT19969", 
                "safety_issue": "No", 
                "time_frame": "40 Days"
            }, 
            {
                "description": "Assessment of the Adverse Events (AEs) and Serious Adverse Events (SAEs) reported within the study", 
                "measure": "To assess the safety and tolerability of SMT19969 compared with vancomycin", 
                "safety_issue": "Yes", 
                "time_frame": "40 days"
            }
        ], 
        "source": "Summit Corporation Plc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Wellcome Trust", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Summit Corporation Plc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}